Medical School News and Research

RSS

Over one third of youths get arrested before 23: Study

A new study published in the journal Pediatrics has shown that by age 23, up to 41 percent of American adolescents and young adults have been arrested at least once for something other than a minor traffic violation.

20 Dec 2011

Alcohol would make present-focused people more aggressive

Drinking enough alcohol to become intoxicated increases aggression significantly in people who have one particular personality trait, according to new research.

20 Dec 2011

IHA, U-M to participate in Pioneer ACO model

The University of Michigan Health System will participate in the Pioneer Accountable Care Organization (ACO) model, in partnership with IHA Health Services Corporation, an Ann Arbor, Mich.-based multi-specialty group practice.

20 Dec 2011

Smoking in women associated with skin cancer: Study

A new study has found a link between tobacco use and skin cancer especially in women. The study found that women who had squamous cell skin cancer were more likely to have smoked than those who were free from the disease. And those who smoked at least 20 years were twice as likely to develop squamous cell skin cancer - a less aggressive form of skin cancer as melanoma.

19 Dec 2011

UCL awarded 20M grant to establish The Leonard Wolfson Experimental Neurology Centre

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.

19 Dec 2011

Studies confirm potential of EarlySense system as risk assessment tool for preventing pressure ulcers

EarlySense, a market leader in proactive patient care solutions, announced today post regulatory approval clinical and interventional study results further confirming the EarlySense contact-free patient monitoring system's high value as a risk assessment tool for preventing pressure ulcers.

19 Dec 2011

UCL to establish new center for treatment of neurodegenerative diseases

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a £20million grant from the Wolfson Foundation, it was announced today.

19 Dec 2011

Increased Sirt1 expression protects against neurodegeneration in HD mouse model

Treatment that increases brain levels of an important regulatory enzyme may slow the loss of brain cells that characterizes Huntington's disease (HD) and other neurodegenerative disorders.

19 Dec 2011

Combination of bevacizumab and chemoradiation safe, effective for nasopharyngeal carcinoma

The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.

17 Dec 2011

New procedure helps reconstruct cricoid cartilage in a cancer patient

When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.

17 Dec 2011

TAU researcher develops capsule endoscope to investigate digestive system

Endoscopes - small cameras or optic fibres that are usually attached to flexible tubing designed to investigate the interior of the body - can be dangerously invasive. Procedures often require sedative medications and some recovery time. Now a researcher at Tel Aviv University is developing a "capsule endoscope" that can move through the digestive tract to detect problems independent of any attachments.

16 Dec 2011

Soligenix secures Harvard option rights to initiate anthrax vaccine development program

Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.

16 Dec 2011

Patients need less blood after surgery than is widely thought

Patients need less blood after surgery than is widely thought. A new study comparing two plans for giving blood transfusions following surgery showed no ill effects from postponing transfusion until patients develop signs of anemia or their hemoglobin concentration falls below 8 g/dL.

16 Dec 2011

New $100M Cooper Cancer Institute in Camden to break ground in April 2012

Sandra and George Norcross today announced a $5 million pledge to Cooper University Hospital. It is the first commitment in a $50 million capital campaign to help fund the rapid expansion of one of New Jersey's preeminent medical centers.

15 Dec 2011

More than half of older patients with anemia do not need transfusions after hip surgery

More than half of the older, anemic patients in a New England Journal of Medicine study did not need blood transfusions as they recovered from hip surgery, according to new research co-authored by University of Maryland School of Medicine scientists.

15 Dec 2011

Vaginal progesterone reduces rate of preterm birth and neonatal complications

A team of investigators of the National Institutes of Health housed at the Detroit Medical Center (DMC) and Wayne State University (WSU) published today that performing a cervical ultrasound in all pregnant women and treating those with a short cervix with vaginal progesterone reduces the rate of preterm birth and neonatal complications.

15 Dec 2011

FDA approves modernized labeling for ViroPharma's Vancocin Capsules

ViroPharma Incorporated today announced the modernization of labeling for Vancocin (vancomycin hydrochloride, USP) Capsules made effective through the U.S. Food and Drug Administration's (FDA) approval of a supplemental new drug application.

15 Dec 2011

New study: Insulin signaling is altered in human pancreas

Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells - the cells that produce insulin.

14 Dec 2011

Promising results from Fate Therapeutics' ProHema Phase 1b trial on hematologic malignancies

Fate Therapeutics, Inc. announced today promising clinical results from a Phase 1b trial of ProHema (FT1050-enhanced umbilical cord blood) as part of double-umbilical cord blood (UCB) transplants in adult patients with hematologic malignancies who have undergone reduced-intensity conditioning therapy.

14 Dec 2011

Study to evaluate effectiveness of cognitive behavioral therapy for BDD

Rhode Island Hospital has received a grant for more than $1.5 million from the National Institute of Mental Health (NIMH) for a 5-year study on treatment for Body Dysmorphic Disorder (BDD). Led by Katharine A. Phillips, M.D., director of the BDD Program at Rhode Island Hospital and an internationally known expert in BDD, the study will examine the effectiveness of cognitive behavioral therapy versus supportive psychotherapy for the treatment of people with BDD.

14 Dec 2011